ATE200620T1 - Duloxetin enthaltende darmlösliche pellets - Google Patents

Duloxetin enthaltende darmlösliche pellets

Info

Publication number
ATE200620T1
ATE200620T1 AT95304977T AT95304977T ATE200620T1 AT E200620 T1 ATE200620 T1 AT E200620T1 AT 95304977 T AT95304977 T AT 95304977T AT 95304977 T AT95304977 T AT 95304977T AT E200620 T1 ATE200620 T1 AT E200620T1
Authority
AT
Austria
Prior art keywords
pellets containing
intestine soluble
containing duloxetine
soluble pellets
duloxetine
Prior art date
Application number
AT95304977T
Other languages
English (en)
Inventor
Neil Robert Anderson
Peter Lloyd Oren
Toshihiro Ogura
Toshiro Fujii
Original Assignee
Lilly Co Eli
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23055767&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE200620(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli, Shionogi & Co filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE200620T1 publication Critical patent/ATE200620T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95304977T 1994-07-18 1995-07-17 Duloxetin enthaltende darmlösliche pellets ATE200620T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/276,232 US5508276A (en) 1994-07-18 1994-07-18 Duloxetine enteric pellets

Publications (1)

Publication Number Publication Date
ATE200620T1 true ATE200620T1 (de) 2001-05-15

Family

ID=23055767

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95304977T ATE200620T1 (de) 1994-07-18 1995-07-17 Duloxetin enthaltende darmlösliche pellets

Country Status (30)

Country Link
US (1) US5508276A (de)
EP (1) EP0693282B1 (de)
JP (1) JP3707831B2 (de)
KR (1) KR100356240B1 (de)
CN (1) CN1106191C (de)
AT (1) ATE200620T1 (de)
AU (1) AU686384B2 (de)
BR (1) BR9503346A (de)
CA (1) CA2153856C (de)
CO (1) CO4410177A1 (de)
CZ (1) CZ288095B6 (de)
DE (1) DE69520711T2 (de)
DK (1) DK0693282T3 (de)
ES (1) ES2157297T3 (de)
GE (1) GEP20063944B (de)
GR (1) GR3036185T3 (de)
HU (1) HU221502B (de)
IL (1) IL114584A (de)
MY (1) MY116361A (de)
NO (2) NO312397B1 (de)
NZ (1) NZ272554A (de)
PE (1) PE32196A1 (de)
PL (1) PL181296B1 (de)
PT (1) PT693282E (de)
RU (1) RU2147231C1 (de)
SI (1) SI0693282T1 (de)
TW (1) TW382596B (de)
UA (1) UA41344C2 (de)
YU (1) YU49445B (de)
ZA (1) ZA955799B (de)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1195287A (zh) * 1995-07-24 1998-10-07 伊莱利利公司 注意力涣散/多动症的治疗
US5910319A (en) * 1997-05-29 1999-06-08 Eli Lilly And Company Fluoxetine enteric pellets and methods for their preparation and use
PT1113797E (pt) 1998-09-15 2009-12-21 Lilly Co Eli Utilização da duloxetina para o tratamento da fibromialgia
EP1027885B1 (de) * 1999-02-09 2008-07-09 Pfizer Products Inc. Zusammensetzungen basischer Arzneistoffe mit verbesserter Bioverfügbarkeit
IL130602A0 (en) * 1999-06-22 2000-06-01 Dexcel Ltd Stable benzimidazole formulation
PL357042A1 (en) * 2000-03-07 2004-07-12 Eli Lilly And Company Treatment of psoriasis
CA2442410A1 (en) * 2001-03-29 2002-10-10 Owen Brendan Wallace Duloxetine for treatment of hot flashes
PL368587A1 (en) * 2001-06-22 2005-04-04 Pfizer Products Inc. Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers
ES2333645T3 (es) * 2001-06-22 2010-02-25 Bend Research, Inc. Composiciones farmaceuticas de dispersiones de medicamentos y polimeros neutros.
MXPA05004935A (es) * 2002-11-19 2005-07-22 Lilly Co Eli Tratamiento de desordenes gastrointestinales con duloxetina.
CA2533577C (en) * 2003-07-24 2014-10-21 Smithkline Beecham Corporation Orally dissolving films
CA2563271A1 (en) * 2004-04-08 2005-10-20 Kyowa Hakko Kogyo Co., Ltd. Solid products with improved stability and method for producing the same
GB0410470D0 (en) * 2004-05-11 2004-06-16 Cipla Ltd Pharmaceutical compound and polymorphs thereof
WO2006071868A2 (en) * 2004-12-23 2006-07-06 Teva Pharmaceutical Industries Ltd. Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof
WO2006096809A1 (en) * 2005-03-08 2006-09-14 Teva Pharmaceutical Industries Ltd. Crystal forms of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine oxalate and the preparation thereof
EP1858859A1 (de) * 2005-03-14 2007-11-28 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung von optisch aktivem (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)-propanamin
WO2007034503A2 (en) * 2005-06-20 2007-03-29 Cadila Healthcare Limited Controlled release dosage formulation of duloxetine
US8153824B2 (en) * 2005-06-22 2012-04-10 The Wockhardt Company Antidepressant oral liquid compositions
DK1915137T3 (da) 2005-08-10 2013-11-04 Add Advanced Drug Delivery Technologies Ltd Oralt præparat med kontrolleret frisætning
US20060165776A1 (en) * 2005-08-31 2006-07-27 Ramesh Sesha Antidepressant oral pharmaceutical compositions
US7842717B2 (en) * 2005-09-22 2010-11-30 Teva Pharmaceutical Industries Ltd. DNT-maleate and methods of preparation thereof
US20080207923A1 (en) * 2005-09-22 2008-08-28 Santiago Ini Pure DNT-maleate and methods of preparation thereof
CA2629800A1 (en) * 2005-11-23 2007-05-31 Thomas G. Gant Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
US7759500B2 (en) * 2005-12-05 2010-07-20 Teva Pharmaceutical Industries Ltd. 2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride
DE102005060393A1 (de) * 2005-12-16 2007-06-21 Add Advanced Drug Delivery Technologies Ltd. Orales Präparat mit kontrollierter Freisetzung
MX2007011611A (es) * 2006-01-23 2007-10-18 Teva Pharma Fumarato de dnt y metodos de preparacion de ellos.
EP1820800A1 (de) * 2006-02-17 2007-08-22 KRKA, tovarna zdravil, d.d., Novo mesto Kristalline Formen von Duloxetine hydrochlorid und Verfahren zu deren Herstellung
KR200416582Y1 (ko) 2006-03-07 2006-05-19 김정배 건강신발
KR20090005237A (ko) * 2006-05-22 2009-01-12 테바 파마슈티컬 인더스트리즈 리미티드 둘록세틴 염산염 지연 방출형 제제
MX2008001079A (es) * 2006-05-23 2008-03-19 Teva Pharma Polimorfos de hidrocloruro de duloxetina.
JP5052051B2 (ja) * 2006-06-16 2012-10-17 トーアエイヨー株式会社 腸溶性顆粒剤及びその製造方法
WO2008020286A2 (en) * 2006-08-14 2008-02-21 Torrent Pharmaceuticals Limited Pharmaceutical compositions of duloxetine
CN101190208B (zh) * 2006-11-30 2011-11-02 石药集团中奇制药技术（石家庄）有限公司 一种含有盐酸度洛西汀的药物制剂及其制备方法
CN101657438A (zh) 2006-12-22 2010-02-24 斯索恩有限公司 制备度洛西汀和相关化合物的方法
US20110008439A1 (en) * 2006-12-27 2011-01-13 Lek Pharmaceuticals D.D. Duloxetin composition
EP2018860A1 (de) * 2007-07-16 2009-01-28 LEK Pharmaceuticals D.D. Duloxetinzusammensetzung
EP1938840A1 (de) * 2006-12-27 2008-07-02 LEK Pharmaceuticals D.D. Duloxetinzusammensetzung
US20080226711A1 (en) * 2007-03-12 2008-09-18 Torrent Pharmaceuticals Ltd. Pharmaceutical compositions of duloxetine
EP2150242A2 (de) * 2007-04-20 2010-02-10 Wockhardt Research Centre Pharmazeutische zusammensetzungen von duloxetin
WO2009004649A2 (en) * 2007-05-21 2009-01-08 Sun Pharmaceutical Industries Limited Enteric coated pharmaceutical compositions
GB0712220D0 (en) * 2007-06-23 2007-08-01 Arrow Int Ltd Duloxetine formulation
WO2009066181A2 (en) * 2007-07-09 2009-05-28 Combino Pharm, S.L. Oral delayed-release duloxentine hydrochloride pellets
WO2009010238A2 (en) * 2007-07-13 2009-01-22 Synthon B.V. Duloxetine formulations
WO2009087657A2 (en) * 2007-11-03 2009-07-16 Alkem Laboratories Ltd. Stable pharmaceutical composition of duloxetine and process for its preparation
EP2240162A4 (de) 2007-12-06 2013-10-09 Bend Res Inc Nanoteilchen mit einem nicht-ionisierbaren polymer und einem amin-funktionalisierten methacrylat-copolymer
US9724362B2 (en) * 2007-12-06 2017-08-08 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
CA2712282A1 (en) * 2008-01-25 2009-07-30 Alphapharm Pty Ltd Delayed release pharmaceutical composition of duloxetine
US20090226517A1 (en) * 2008-02-06 2009-09-10 Vinita Umashankar Vyas Pharmaceutical formulations comprising duloxetine
WO2009118756A2 (en) * 2008-03-24 2009-10-01 Lupin Limited Delayed release compositions of duloxetine
EP2293782B1 (de) * 2008-05-06 2015-08-12 Dexcel Pharma Technologies Ltd. Stabile benzimidazolformulierung
EP2133072A1 (de) 2008-06-13 2009-12-16 KRKA, D.D., Novo Mesto Magenresistente orale pharmazeutische Zusammensetzungen mit Duloxetin oder pharmazeutisch zulässigen Derivaten
US20100040680A1 (en) * 2008-08-15 2010-02-18 Felix Lai Multiparticulate selective serotonin and norepinephrine reuptake inhibitor formulation
WO2010037849A1 (en) * 2008-10-02 2010-04-08 Laboratorios Del Dr. Esteve, S.A. Duloxetine enteric pellets
CN101756960B (zh) 2008-12-26 2012-06-27 上海中西制药有限公司 一种度洛西汀肠溶制剂及其芯材和制备方法
WO2010078878A1 (en) * 2009-01-12 2010-07-15 Synthon B.V. Duloxetine formulations
WO2010150219A1 (en) 2009-06-25 2010-12-29 Wockhardt Research Centre Pharmaceutical composition of duloxetine or pharmaceutically acceptable salts thereof
DE102009033621A1 (de) 2009-07-17 2011-01-20 Add Technologies Ltd. Trennschichten für pharmazeutische Zubereitungen zur Verhinderung von Wechselwirkungen zwischen Arzneistoffen und pharmazeutisch-technologischen Hilfsstoffen
EP2477614A2 (de) * 2009-09-17 2012-07-25 Cadila Healthcare Limited Pharmazeutische zusammensetzungen zur reduktion von alokoholinduzierter schneller dosisfreisetzung
EP2512455B8 (de) * 2009-12-18 2014-07-23 FrieslandCampina Nederland Holding B.V. Co-verarbeitete tablettenunterstützungszusammensetzung sowie ihre herstellung und verwendung
SG183993A1 (en) * 2010-03-09 2012-10-30 Alkermes Pharma Ireland Ltd Alcohol resistant enteric pharmaceutical compositions
EP2377525A1 (de) * 2010-03-26 2011-10-19 Laboratorios del Dr. Esteve S.A. Enterische Duloxetin-Tabletten
WO2011148380A1 (en) * 2010-05-25 2011-12-01 Hetero Research Foundation Oral pharmaceutical composition of duloxetine
CN102908331A (zh) * 2011-08-01 2013-02-06 浙江九洲药物科技有限公司 一种盐酸度洛西汀肠溶胶囊及其制备方法
ES2655622T3 (es) 2012-04-30 2018-02-20 Tillotts Pharma Ag Una formulación de fármaco de liberación retardada
ES2728850T3 (es) 2012-05-02 2019-10-29 Capsugel Belgium Nv Dispersiones acuosas de acetato acetato succinato de hidroxipropilmetilcelulosa (HPMCAS)
CN103505421B (zh) * 2012-06-29 2018-04-27 石药集团中奇制药技术（石家庄）有限公司 一种盐酸度洛西汀的肠溶微丸制剂
CN103211777A (zh) * 2013-03-31 2013-07-24 北京万全阳光医学技术有限公司 一种盐酸度洛西汀的药物制剂及其制备的方法
GR1008228B (el) * 2013-04-23 2014-06-16 "Φαρματεν Α.Β.Ε.Ε.", Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου
EP2813218B1 (de) * 2013-06-14 2022-08-24 Shin-Etsu Chemical Co., Ltd. Verfahren zur herstellung einer wässrigen enterischen beschichtungsflüssigkeit, feststoffpräparat und verfahren zur herstellung davon
CN103393615B (zh) * 2013-07-24 2015-07-15 海南华益泰康药业有限公司 一种度洛西汀肠溶小丸及其制备方法
PL224543B1 (pl) 2013-08-21 2017-01-31 Pabianickie Zakłady Farm Polfa Spółka Akcyjna Dojelitowa tabletka duloksetyny
NZ717159A (en) 2013-10-29 2019-06-28 Tillotts Pharma Ag A delayed release drug formulation
EP3065720A1 (de) 2013-11-04 2016-09-14 Capsugel Belgium NV Verfahren und systeme zur verbesserten bioverfügbarkeit von aktiven pharmazeutischen inhaltsstoffen mit esomeprazol
US9782356B2 (en) * 2014-05-20 2017-10-10 Dow Global Technologies Llc Capsule shells comprising an esterified cellulose ether
CA2962192A1 (en) * 2014-08-22 2016-02-25 Medipath, Inc. Compositions and methods for cannabinoid coatings for use in drug delivery
US10471152B2 (en) * 2014-08-29 2019-11-12 Capsugel Belgium Nv Colloidal dispersion comprising HPMCAS
US20170182070A1 (en) 2014-10-08 2017-06-29 Mayne Pharma International Pty Ltd. Controlled Release Doxycycline
US9668975B2 (en) 2014-10-14 2017-06-06 PharmaDax Inc. Method of preparing drug agglomerate
CN105726488B (zh) * 2014-12-08 2020-10-20 上海爱科百发生物医药技术有限公司 含有呼吸道合胞病毒抑制剂的肠溶微丸及其制备方法
KR101625344B1 (ko) 2015-12-21 2016-06-08 주식회사 유영제약 세레콕시브 및 둘록세틴을 함유하는 약제학적 조성물
CN105534949A (zh) * 2016-01-06 2016-05-04 北京修正创新药物研究院有限公司 一种盐酸度洛西汀的肠溶微丸制剂
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP6815109B2 (ja) * 2016-06-23 2021-01-20 キョーリンリメディオ株式会社 デュロキセチンまたは薬学的に許容されるその塩を有効成分とする医薬組成物
JP6856326B2 (ja) * 2016-07-15 2021-04-07 富士化学工業株式会社 腸放出粒子組成物
CN106166144A (zh) * 2016-08-12 2016-11-30 海南合瑞制药股份有限公司 一种盐酸度洛西汀肠溶胶囊药物组合物
JP2018172361A (ja) * 2016-10-14 2018-11-08 大原薬品工業株式会社 光安定性を改善した、デュロキセチンを含有する固形製剤
US9839626B1 (en) 2016-12-14 2017-12-12 Sun Pharmaceutical Industries Limited Duloxetine sprinkles
JP7072431B2 (ja) * 2017-04-14 2022-05-20 富士化学工業株式会社 錠剤及びその製造方法
JP6972674B2 (ja) * 2017-06-06 2021-11-24 ニプロ株式会社 経口医薬製剤
JP2020029447A (ja) * 2018-06-25 2020-02-27 大原薬品工業株式会社 腸溶性高分子及び抗付着剤を含有する顆粒
CN115844846B (zh) * 2018-10-25 2025-08-05 上海上药中西制药有限公司 盐酸度洛西汀肠溶制剂、其主药层及其混悬液、其隔离层及其包衣液、及其制备方法
JP7050714B2 (ja) * 2019-04-04 2022-04-08 信越化学工業株式会社 腸溶性コーティング用組成物及び固形製剤の製造方法
JP2020189815A (ja) * 2019-05-23 2020-11-26 東和薬品株式会社 デュロキセチン製剤およびその安定化方法
WO2021043723A1 (en) 2019-09-02 2021-03-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treating pax6- deficiency related disease
WO2021126098A1 (en) * 2019-12-18 2021-06-24 Santa Farma İlaç Sanayi̇ A.Ş. Gastro-resistant pellet comprising duloxetine
WO2021126099A1 (en) * 2019-12-18 2021-06-24 Santa Farma İlaç Sanayi̇ A.Ş. An enteric coated pellet comprising duloxetine hydrochloride with optimized degrees of neutralization
WO2022115054A1 (en) * 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Enteric coated duloxetine compositions
CN116251078B (zh) * 2021-12-09 2025-12-19 河北以岭医药研究院有限公司 一种盐酸度洛西汀肠溶胶囊及其制备方法
WO2024117996A1 (en) * 2022-11-30 2024-06-06 Santa Farma Ilac Sanayii A.S. Bioequivalent oral pharmaceutical composition comprising duloxetine hydrochloride
EP4681704A1 (de) 2024-07-18 2026-01-21 BIOPROJET Pharma Neue formulierungen von pitolisant

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS517116A (en) * 1974-06-11 1976-01-21 Shinetsu Chemical Co Choyoseihifukuyakuzaino seizohoho
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
US5019302A (en) 1986-03-12 1991-05-28 Washington University Technology Associates, Inc. Method for granulation
US5100592A (en) 1986-03-12 1992-03-31 Washington University Technology Associated, Inc. Method and apparatus for granulation and granulated product
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
JPH04346930A (ja) * 1991-05-25 1992-12-02 Sumitomo Pharmaceut Co Ltd 安定なアスピリン腸溶錠
RU2024526C1 (ru) * 1991-10-08 1994-12-15 Институт органической химии Уральского отделения РАН 5h- 3,4,6,7- тетрагидро-10- метокси-5-метил-6- (1',1'- диоксидо-3'- мета- хлоранилино-4'- метокси- бензо [в] тиофен -7'-ил) -фуро[4,3,2-q] [3]бензазоцин, обладающий антидепрессивным действием
RU2024520C1 (ru) * 1991-10-08 1994-12-15 Институт органической химии Уральского отделения РАН 10-метокси-5- метил-6- (1',1'- диоксидо-2'- метахлорфенилазо -3'- гидрокси -4'-метоксибензо(в)тиофен- 7-ил) -5h-3,4,6,7- тетрагидрофуро [4.3.2-q] [3]бензазоцин, обладающий антидепрессивным действием
ZA93694B (en) * 1993-02-01 1993-06-03 Lilly Co Eli Pharmaceutical treatments.
US5362886A (en) * 1993-10-12 1994-11-08 Eli Lilly And Company Asymmetric synthesis

Also Published As

Publication number Publication date
PL181296B1 (pl) 2001-07-31
IL114584A0 (en) 1995-11-27
CO4410177A1 (es) 1997-01-09
PE32196A1 (es) 1996-08-07
EP0693282A2 (de) 1996-01-24
HU221502B (en) 2002-10-28
ZA955799B (en) 1997-01-13
HUT72466A (en) 1996-04-29
GR3036185T3 (en) 2001-10-31
ES2157297T3 (es) 2001-08-16
BR9503346A (pt) 1996-02-27
PT693282E (pt) 2001-07-31
US5508276A (en) 1996-04-16
JP3707831B2 (ja) 2005-10-19
YU49445B (sh) 2006-03-03
PL309588A1 (en) 1996-01-22
CA2153856C (en) 2005-05-10
MY116361A (en) 2004-01-31
YU48095A (sh) 1998-07-10
EP0693282A3 (de) 1996-12-18
NO312397B1 (no) 2002-05-06
SI0693282T1 (en) 2002-02-28
EP0693282B1 (de) 2001-04-18
GEP20063944B (en) 2006-10-10
NO2005002I2 (no) 2009-10-05
CA2153856A1 (en) 1996-01-19
NO952786L (no) 1996-01-19
NO2005002I1 (no) 2005-02-28
JPH0840895A (ja) 1996-02-13
KR960003722A (ko) 1996-02-23
AU686384B2 (en) 1998-02-05
CN1106191C (zh) 2003-04-23
KR100356240B1 (ko) 2002-12-26
CN1128141A (zh) 1996-08-07
CZ288095B6 (cs) 2001-04-11
CZ180595A3 (en) 1996-03-13
DE69520711D1 (de) 2001-05-23
DK0693282T3 (da) 2001-05-07
TW382596B (en) 2000-02-21
HU9502134D0 (en) 1995-09-28
UA41344C2 (uk) 2001-09-17
AU2505195A (en) 1996-02-01
IL114584A (en) 1999-09-22
RU2147231C1 (ru) 2000-04-10
DE69520711T2 (de) 2001-09-20
NZ272554A (en) 1996-11-26
NO952786D0 (no) 1995-07-13

Similar Documents

Publication Publication Date Title
ATE200620T1 (de) Duloxetin enthaltende darmlösliche pellets
SE9801336D0 (sv) Enterala fluoxetin-piller
ID21115A (id) Isokuinolin-3-karboksamida tersubstitusi, pembuatannya serta penggunaannya sebagai obat
DE68905224D1 (de) Transendoskopische implantatkapsel.
FI972292A0 (fi) Administrering av diabetes
ATE98480T1 (de) Arzneimittelformulierungen.
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
BRPI9810519B1 (pt) derivados de 4''-substituìdo-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
DE69529598D1 (de) Arzneimittelenthaltende Manschette
ATE238776T1 (de) Geschmacksmaskierte pharmazeutische dosisform mit schneller freisetzung
DE69011059D1 (de) Heterozyklische Acylaminothiazolderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DK0921812T4 (da) Insulinpræparater, som indeholder et halogenid
FI894717A7 (fi) Anordning foer maetning av lokalt och tidsavhaengigt upptraedande svaga biomagnetiska faelt i kroppen hos en patient.
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
FR2762213B1 (fr) Composition pharmaceutique a retention gastrique
ATE14015T1 (de) Oxazolderivate, ihre herstellung und ihre verwendung.
PT840735E (pt) Resolucao de 2-(difenilmetil)-n-{¬2-metoxi-5-(1-metiletil)fenil|metil}-1-azabiciclo¬2.2.2|octan-3-amina
ECSP982517A (es) Granulos entericos de fluoxetina
IS4288A (is) 2,4-dísúlfónýlfenýlbútýlnítrón, sölt þess, lyfjablanda ásamt notkun á þessu efnasambandi við framleiðslu á lyfi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification